CLINICAL_TRIALS
trial_result
· 2018-04-12
Clinical Trial Update: Eflornithine in Treating Patients At High Risk of Developing Prostate Cancer [Phase 2]
Summary
A Phase 2 trial of eflornithine in men at high risk of developing prostate cancer has completed enrollment and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Thomas E. Ahlering | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-04-12